Skip to content

Nipple sensitivity after prophylactic nipple-sparing mastectomy compared to healthy BRCA1/2 gene mutation carriers.

Nipple sensitivity after prophylactic nipple-sparing mastectomy compared to healthy BRCA1/2 gene mutation carriers. - NISPRO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON37622
Enrollment
50
Registered
2012-09-05
Start date
2012-05-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast amputation sparing the nipple nipple sparing mastectomy

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: BRCA1/BRCA2 gene mutation carriers who underwent a prophylactic nipple sparing mastectomy, at least one year after operation.

Exclusion criteria

Exclusion criteria: history of breast cancer

Design outcomes

Primary

MeasureTime frame
Nipple sensitivity, mean scores per nipple. Results of the questionnaire: body image, satisfaction with the operation.

Secondary

MeasureTime frame
Co-morbidity: diabetes mellitus, BMI Smoking status Post-operative complications: wound infection, necrosis of the nipple, re-operation

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)